Full-Time

Senior Scientist I

Computational Biology & Machine Learning, 24204-U-670-CBIO

Posted on 4/19/2024

ArsenalBio

ArsenalBio

201-500 employees

Develops CRISPR-enabled solid tumor cell therapies

Data & Analytics
AI & Machine Learning

Compensation Overview

$127,300 - $156,000Annually

Senior, Expert

San Bruno, CA, USA

Required Skills
Python
Data Analysis
Requirements
  • Ph.D. in Bioinformatics, Computer Science, Electrical Engineering, Statistics, Biomedical Engineering, Biology, or a related field with 2+ years of industry experience, OR Masters with 7+ years of industry experience, OR Bachelors with 9+ years of industry experience
  • Demonstrated ability to apply data analysis and engineering skills to answer biological questions
  • Hands-on experience analyzing next generation sequencing data
  • Hands-on experience developing deep learning models
  • Ability to work collaboratively and communicate effectively in an interdisciplinary environment
  • Proficiency in Python
  • Experience working in Linux environments
Responsibilities
  • Develop machine learning / deep learning models to extract insights from large screening experiments
  • Analyze data from next generation sequencing assays (eg. RNA-seq, single-cell RNA-seq, ATAC-seq), flow cytometry, or other related technologies
  • Work closely with ArsenalBio scientists across different functions and disciplines to rapidly iterate through the cycle of experimental design, hypothesis testing, data collection, and interpretation
  • Assist with experimental design, for example through modeling or simulations
  • Help productionize computational workflows so that they can be executed in a robust and reproducible manner
  • Develop visualization tools

Arsenal Bio utilizes advanced CRISPR-enabled genome editing and integrated circuits with logic gate technology, making it a forefront player in the field of biotechnology, specifically in the development of cell therapies for solid tumors. This focus not only addresses complex medical challenges but also contributes to significant advancements in therapeutic applications. The company's commitment to combining cutting-edge technology with pharmaceutical enhancements makes it a promising workplace for those keen on impacting healthcare innovation and cancer treatment.

Company Stage

Series B

Total Funding

$525.8M

Headquarters

South San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

2%

2 year growth

44%

Benefits

Medical, dental, & vision coverage

Virtual & telehealth options

Parental leave

Flexible work schedule

Flexible PTO

Mental health resources

INACTIVE